CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
41.76 0.14(0.34%) NAV as on 19 Jun 2026
-0.67 % 1 M
8.95 % 1 Y
25.61 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.41

As on 30 Apr, 2026
age-icon Age :

7 yrs 11 m

Since 13 07 ,2018
exit_load Exit Load :

1%

aum AUM :

6,453.52 Crs

lock_in Lock-in :

1% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

5.6

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dharmesh Kakkad

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2026
Others 0.18 %
Equity 99.82 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.09 %
Dr. Reddy's Laboratories Ltd.7.70 %
Cipla Ltd.7.45 %
Mankind Pharma Ltd.7.03 %
Divi's Laboratories Ltd.6.06 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs78.74
Hospital & Healthcare Services9.13
Business Support4.36
Retailing3.86
Trading1.74
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)19.6918.6430.2036.2036.61
Net Assets(Rs Crores) (as on 31-Mar-2026) 2500.42 2594.59 3772.32 4914.64 6293.14
Scheme Returns(%)(Absolute)12.51-5.3861.1518.222.15
B'mark Returns(%)(Absolute)NANANANANA
Category Rank47/7563/7612/906/10233/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.760.14(0.34%)NAV As on 19 Jun, 202613-Jul-2018Inception Date6,453.52AUM In Cr.8.95%1Y25.61%3Y15.79%5Y19.72%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity476.633.15(0.67%)NAV As on 19 Jun, 202614-Jul-1999Inception Date4,565.95AUM In Cr.14.65%1Y23.76%3Y16.30%5Y16.12%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity42.540.35(0.82%)NAV As on 19 Jun, 202602-Jul-2018Inception Date3,090.51AUM In Cr.14.88%1Y23.58%3Y14.54%5Y19.92%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity33.800.21(0.63%)NAV As on 19 Jun, 202610-Jul-2019Inception Date950.31AUM In Cr.14.15%1Y22.36%3Y13.05%5Y19.16%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity31.740.12(0.38%)NAV As on 19 Jun, 202628-Dec-2015Inception Date1,386.99AUM In Cr.8.28%1Y21.38%3Y13.76%5Y11.65%Since Inception